On February 19, 2026, SINTX Technologies (SINT) disclosed one insider transaction. Director Anderson Mark Lewis purchased 3,000 shares on February 18, 2026.
[Recent Insider Transactions]
Disclosure Date
Position
Name
Transaction Date
Buy/Sell
Quantity
Price per Share/USD
Total Amount/USD
February 19, 2026
Director
Anderson Mark Lewis
February 18, 2026
Buy
3,000
3.02
9,060.00
December 9, 2025
Director
Honigblum Gregg R.
December 8, 2025
Buy
3,200
4.28
13,700
December 9, 2025
Director
Honigblum Gregg R.
December 8, 2025
Buy
5,000
4.24
21,200
December 8, 2025
Director
Honigblum Gregg R.
December 5, 2025
Buy
5,000
4.02
20,100
December 8, 2025
Director
Honigblum Gregg R.
December 5, 2025
Buy
5,000
3.94
19,700
December 8, 2025
Director
Honigblum Gregg R.
December 5, 2025
Buy
5,000
4.00
20,000
December 8, 2025
Director
Honigblum Gregg R.
December 5, 2025
Buy
5,000
3.88
19,400
December 8, 2025
Director
Honigblum Gregg R.
December 5, 2025
Buy
5,000
3.77
18,900
December 8, 2025
Director
Honigblum Gregg R.
December 5, 2025
Buy
5,000
3.86
19,300
December 8, 2025
Director
Honigblum Gregg R.
December 5, 2025
Buy
20,000
3.91
78,200
[Company Profile]
SINTX Technologies, Inc. was incorporated in Delaware on December 10, 1996. SINTX Technologies is an innovative biomaterials and OEM company that develops and commercializes silicon nitride for various biomedical applications, including spinal, dental, oral-maxillofacial, podiatric, and joint replacement markets.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
US Stock Insider Trading | SINTX Technologies disclosed 1 insider transaction on February 19
On February 19, 2026, SINTX Technologies (SINT) disclosed one insider transaction. Director Anderson Mark Lewis purchased 3,000 shares on February 18, 2026.
[Recent Insider Transactions]
[Company Profile]
SINTX Technologies, Inc. was incorporated in Delaware on December 10, 1996. SINTX Technologies is an innovative biomaterials and OEM company that develops and commercializes silicon nitride for various biomedical applications, including spinal, dental, oral-maxillofacial, podiatric, and joint replacement markets.